Merit Medical Systems | MMSI - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
3M USD 921M 140M 2026-09
Abbott USD 4.27B 669M 2026-09
AngioDynamics USD 36.57M 3.79M 2025-09
Anika Therapeutics USD 10.01M 14K 2025-12
AtriCure USD 82.88M 319K 2026-09
Baxter International USD 730M 5M 2026-09
Becton, Dickinson and Co. USD 1.26B 1000K 2026-09
Boston Scientific USD 1.68B 120M 2026-09
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 560.9M 300K 2026-09
Globus Medical USD 288.47M 1.65M 2026-09
Haemonetics USD 118.36M 580K 2026-09
ICU Medical USD 154.41M 2.48M 2026-09
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
J&J USD 6.25B 168M 2026-09
Medtronic 3.2B 141M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Olympus JPY 125.03B 14.31B 2026-06
Pfizer USD 3.28B 132M 2026-09
STAAR Surgical USD 43.22M 1.92M 2026-09
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 113.94M 2.3M 2026-09
Teleflex USD 220.72M 7.21M 2026-09
Terumo JPY 109.7B 5.11B 2026-06
Zimmer Biomet Holdings USD 855M 56.6M 2026-09